Literature DB >> 12639502

Neurotoxicity induced in differentiated SK-N-SH-SY5Y human neuroblastoma cells by organophosphorus compounds.

Marjorie S Hong1, Sandra J Hong, Rola Barhoumi, Robert C Burghardt, K C Donnelly, James R Wild, Vijayanagaram Venkatraj, Evelyn Tiffany-Castiglioni.   

Abstract

Organophosphorus (OP) compounds used as insecticides and chemical warfare agents are known to cause potent neurotoxic effects in humans and animals. Organophosphorus-induced delayed neuropathy (OPIDN) is currently thought to result from inhibition of neurotoxic esterase (NTE), but the actual molecular and cellular events leading to the development of OPIDN have not been characterized. This investigation examined the effects of OP compounds on the SY5Y human neuroblastoma cells at the cellular level to further characterize cellular targets of OP neurotoxicity. Mipafox and paraoxon were used as OP models that respectively do and do not induce OPIDN. Mipafox (0.05 mM) significantly decreased neurite length in SY5Y cells differentiated with nerve growth factor (NGF) while paraoxon at the same concentration had no effect when evaluated after each of three 4-day developmental windows during which cells were treated daily with OP or vehicle. In contrast, paraoxon but not mipafox altered intracellular calcium ion levels ([Ca(2+)](i)), as seen in three types of experiments. First, immediately following the addition of a single high concentration of OP to the culture, paraoxon caused a transient increase in [Ca(2+)](i), while mipafox up to 2 mM had no effect. Paraoxon hydrolysis products could also increase intracellular Ca(2+) levels, although the pattern of rise was different than it appeared immediately after paraoxon administration. Second, repeated low-level paraoxon treatment (0.05 mM/day for 4 days) decreased basal [Ca(2+)](i) in NGF-differentiated cells, though mipafox had no effect. Third, carbachol, a muscarinic acetylcholine receptor agonist, transiently increased [Ca(2+)](i) in differentiated cells, an affect attenuated by 4-day pretreatment with paraoxon (0.05 mM/day), but not by pretreatment with mipafox. These results indicate that the decrease in neurite extension that resulted from mipafox treatment was not caused by a disruption of Ca(2+) homeostasis. The effects of OPs that cause or do not cause OPIDN were clearly distinguishable, not only by their effects on neurite length, but also by their effects on Ca(2+) homeostasis in differentiated SY5Y cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12639502     DOI: 10.1016/s0041-008x(02)00016-9

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  11 in total

1.  Inhibition of neuropathy target esterase expressing by antisense RNA does not affect neural differentiation in human neuroblastoma (SK-N-SH) cell line.

Authors:  Ping-An Chang; Yi-Jun Wu; Rui Chen; Ming Li; Wei Li; Qi-Lian Qin
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

2.  Oxidative stress resulting from exposure of a human salivary gland cells to paraoxon: an in vitro model for organophosphate oral exposure.

Authors:  John M Prins; Chih-Kai Chao; Saskia M Jacobson; Charles M Thompson; Kathleen M George
Journal:  Toxicol In Vitro       Date:  2014-01-29       Impact factor: 3.500

3.  Effect of tri-o-cresyl phosphate on cytoskeleton in human neuroblastoma SK-N-SH cell.

Authors:  Ping-An Chang; Yi-Jun Wu
Journal:  Mol Cell Biochem       Date:  2006-08-15       Impact factor: 3.396

4.  Paraoxon-induced protein expression changes to SH-SY5Y cells.

Authors:  John M Prins; Kathleen M George; Charles M Thompson
Journal:  Chem Res Toxicol       Date:  2010-10-08       Impact factor: 3.739

5.  Motor neuron disease due to neuropathy target esterase mutation: enzyme analysis of fibroblasts from human subjects yields insights into pathogenesis.

Authors:  Nichole D Hein; Shirley R Rainier; Rudy J Richardson; John K Fink
Journal:  Toxicol Lett       Date:  2010-09-17       Impact factor: 4.372

6.  Induction of autophagy in human neuroblastoma SH-SY5Y cells by tri-ortho-cresyl phosphate.

Authors:  Ding-Xin Long; Dan Hu; Pan Wang; Yi-Jun Wu
Journal:  Mol Cell Biochem       Date:  2014-07-03       Impact factor: 3.396

7.  Functional pathways altered after silencing Pnpla6 (the codifying gene of neuropathy target esterase) in mouse embryonic stem cells under differentiation.

Authors:  David Pamies; Eugenio Vilanova; Miguel A Sogorb
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-10-19       Impact factor: 2.416

8.  Identification of differentially expressed genes in SHSY5Y cells exposed to okadaic acid by suppression subtractive hybridization.

Authors:  Vanessa Valdiglesias; Juan Fernández-Tajes; Eduardo Pásaro; Josefina Méndez; Blanca Laffon
Journal:  BMC Genomics       Date:  2012-01-27       Impact factor: 3.969

9.  Genomic and phenotypic alterations of the neuronal-like cells derived from human embryonal carcinoma stem cells (NT2) caused by exposure to organophosphorus compounds paraoxon and mipafox.

Authors:  David Pamies; Miguel A Sogorb; Marco Fabbri; Laura Gribaldo; Angelo Collotta; Bibiana Scelfo; Eugenio Vilanova; Georgina Harris; Anna Bal-Price
Journal:  Int J Mol Sci       Date:  2014-01-09       Impact factor: 5.923

10.  Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies.

Authors:  Sandra Coecke; Alan M Goldberg; Sandra Allen; Leonora Buzanska; Gemma Calamandrei; Kevin Crofton; Lars Hareng; Thomas Hartung; Holger Knaut; Paul Honegger; Miriam Jacobs; Pamela Lein; Abby Li; William Mundy; David Owen; Steffen Schneider; Ellen Silbergeld; Torsten Reum; Tomas Trnovec; Florianne Monnet-Tschudi; Anna Bal-Price
Journal:  Environ Health Perspect       Date:  2007-02-06       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.